LEANPHARMA Competitors

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Zentiva provides health and wellbeing for all generations, with focus on developing, producing, and delivering high-quality, affordable medicines to more than 100 million people in over 40 countries across Europe and beyond. Zentiva has four manufacturing sites and a broad network of external manufacturing partners. Zentiva employs more than 5,400 unique talents, bonded together by a commitment to the people who depend on our products every day. Visit us at www.zentiva.com. Data protection: It’s not just a checkbox – it’s our commitment! Please visit our Privacy Notice https://www.zentiva.com/gdpr/privacy-notice

Medochemie Ltd was established in 1976 by Dr. Andreas Pittas and has since evolved into the largest pharmaceutical company in Cyprus and one of the top 200 generic drug manufacturers globally. Our growth reflects the broader rise of generics in global healthcare by moving from a limited role to a key provider of high-quality, affordable medicines worldwide. Today, we operate fifteen state-of-the-art manufacturing facilities: nine in Cyprus, one in the Netherlands, and five in Vietnam. Our production capabilities allow us to export to 122 countries, supported by 19 core offices and an extended network of trusted agents and partners. Our portfolio includes 630 pharmaceutical products under 5,145 marketing authorisations, spanning over 10 therapeutic categories, including prescription and over-the-counter medicines. Our team of 2,000 skilled professionals, 45% of whom are scientists, drives our commitment to excellence, innovation, and strict adherence to international quality standards. Medochemie is proud to contribute significantly to Cyprus' economy, accounting for 28.9% of the country’s industrial exports. We are also a founding member of Medicines for Europe (formerly EGA).